Bank of America’s Charles River Laboratories CRL Stock Holding History

Bank of America’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$1.96M	–	8032
2023 Q3	$1.96M	Buy	+10,000	New	+$2.05M	﹤0.01%	4259
2021 Q2	–	Sell	-10,000	Closed	-$2.9M	–	7793
2021 Q1	$2.9M	Buy	+10,000	New	+$2.78M	﹤0.01%	3920
2017 Q3	–	Sell	-44,600	Closed	-$4.51M	–	7076
2017 Q2	$4.51M	Buy	+44,600	New	+$4.11M	﹤0.01%	3131
2014 Q1	–	Sell	-60,000	Closed	-$3.18M	–	7826
2013 Q4	$3.18M	Buy	+60,000	New	+$3.01M	﹤0.01%	2879
2013 Q3	–	Sell	-7,500	Closed	-$308K	–	7885
2013 Q2	$308K	Buy	+7,500	New	+$321K	﹤0.01%	5206

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America's CRL Position: Q1 2026 in Review

Bank of America increased its Charles River Laboratories (CRL) stake by 5% in Q1 2026, buying an estimated $10.1M and bringing the position to 1,135,027 shares worth $196M. The position accounts for 0.01% of the portfolio, ranked #748.

Bank of America first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $241M in Q1 2024. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Bank of America held 1,135,027 shares of Charles River Laboratories worth $196M as of Q1 2026.
Bank of America bought 54,500 Charles River Laboratories shares in Q1 2026, an estimated $10.1M.
Charles River Laboratories made up 0.01% of Bank of America's portfolio in Q1 2026, its #748 holding.
Bank of America first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
Bank of America's Charles River Laboratories position peaked at $241M in Q1 2024.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.